Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

2 terminated/withdrawn out of 8 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

5(62.5%)

Phase 1

2(25.0%)

Phase 4

1(12.5%)

8Total

N/A(5)

Phase 1(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06533163Not ApplicableRecruiting

Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial

Role: lead

NCT04807387Not ApplicableTerminated

Newly Designed Vaginal Stent to Improve Patient Comfort and Healing Following Vaginal Surgery or Vaginal Radiation

Role: collaborator

NCT00688038Phase 4Completed

Correlation of MR Thermal Imaging to Actual Size of Ablation During Laser Ablation Therapy

Role: collaborator

NCT01065948Phase 1Completed

A Feasibility Study to Assess Critical Aspects of Fluorescence Affinity Sensor (FAS) Performance and Safety Over Several Hours

Role: lead

NCT00720837Not ApplicableTerminated

Magnetic Resonance Temperature Imaging & Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors

Role: collaborator

NCT00615537Not ApplicableCompleted

Pilot Study on Laser Ablation of Symptomatic Benign Thyroid Masses

Role: lead

NCT00392366Not ApplicableCompleted

Laser Interstitial Thermal Therapy Under "Real Time" MRI Guidance for "Minimal Invasive" Treatment of Liver Metastasis

Role: lead

NCT00392119Phase 1Completed

MR Guided Laser Interstitial Thermal Therapy for the "Minimal Invasive" Treatment of Brain Metastasis and Primary Brain Tumors

Role: lead

All 8 trials loaded